Turkey Dermatology Treatment Drugs Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : February 2022
  • Region: Turkey
  • Country: Other
  • Report ID : 5102

  • Format: PPT, PDF

Turkey Dermatology Treatment Drugs Market Analysis: Segmented by Dermatological Disease, Drug Class, Prescription Mode, Route of Administration, End-User, Distribution Channel – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5102 Categories: ,

Report Description of the Turkey Dermatology Treatment Drugs Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Turkey Dermatology Treatment Drugs Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Turkey Dermatology Treatment Drugs Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

Turkey Dermatology Treatment Drugs Market Analysis Executive Summary

Dermatology is defined as a therapy area which deals with diseases of the skin, hair, and nails, where the most common conditions are psoriasis, eczema, and acne vulgaris. Dermatology drugs are used in the management and treatment of diseases related to skin, nail, hair, and genital membranes.

Market Size and Key Findings

The Turkey Dermatology Treatment Drugs Market Analysis size stood at around USD xx% billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

Rising expenditure on personal care is the vital factor escalating the market growth, also rising awareness towards skin disease, rising number of patients suffering from acne, vitiligo, and dermatitis, rising demand for effective products to cure skin infections and disorders coupled with high awareness among the young population, rising demand for effective dermatological treatments and the increase in number of companies investing in the market are major factors among others driving the dermatology drugs market. Moreover, rising technological advancements and modernization in the healthcare machinery, rising research and development activities in the healthcare sector and rising emerging markets will further create new opportunities for dermatology drugs market in the forecasted period of 2021-2028.

Market Restraints

Serious side effects of certain classes of therapeutic drugs are expected to restrain the market growth in the near future. Moreover, Stringent Regulations for Dermatology Drugs and High Cost of Dermatology Drugs are assumed to be restraining the Turkey Dermatology Drugs Market.

Covid-19 Market Impact Analysis

The COVID-19 pandemic has had a significant impact on the healthcare system. It has reduced the growth rate of the market due to the rapid shift in focus toward COVID-19 treatment. As a result, the majority of the hospitals have delayed vaccinations pertaining to dermatology, chemotherapy sessions, and other non-essential services.

Competitive Landscape

Key Players

The major players covered in the report are Novartis AG, Pfizer Inc., Eli Lilly and Company., Johnson & Johnson Services, Inc., Almirall, S.A, Mylan N.V., Sun Pharmaceutical Industries Ltd., UCB S.A., Belgium, Glenmark Pharmaceuticals Limited, Tolmar Pharmaceuticals, Inc., GlaxoSmithKline plc., Galderma Laboratories, L.P., Teva Pharmaceutical Industries Ltd., LEO Pharma A/S, MELINTA THERAPEUTICS, INC. – THE ANTIBIOTICS COMPANY, Mayne Pharma Group Limited, BIOFRONTERA AG, AbbVie Inc. among others.

Products in Pipeline

  • The first market access agreement has been signed for the products used in the treatment of Hepatitis C. The products have received reimbursement approval since June 18, 2016.
  • Biofrontera AG has got approval from the European Medicines Agency (EMA). This fivefold increase in the production of Ameluz benefits Biofrontera AG to meet the growing demand for Ameluz in all the regions.

Notable Recent Deals

  • In February 2019, Mayne Pharma Group Limited announced that they have launched the drug LEXETTE (halobetasol propionate) foam 0.05% in the United States.
  • In January 2020, Bayer and Azitra Inc. announced a joint development agreement to leverage Azitra’s proprietary panel of Staphylococcus epidermidis strains to identify potential candidates for the treatment of adverse skin conditions and diseases.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario    

Reimbursement agencies are increasingly adopting innovative reimbursement approaches for new and expensive technologies. Social Security Institution (SSI), Turkey`s reimbursement agency, established the Alternative Reimbursement Commission (ARC) on February 10, 2016.

In Turkey, depending on the drug licensing and pricing activity, monitoring and management of the Ministry of Health Turkey Pharmaceuticals and Medical Devices Agency (TPMDA) is implemented through the licensing application by pharmaceutical manufacturers. The “Human Medicinal Products Licensing Regulation” is implemented by TPMDA. The drug reimbursement is made by the Social Security Institution (SSI), which is affiliated to the Ministry of Family, Labor, and Social Services. The most important criteria for reimbursement are clinical effectiveness, safety, quality, cost-effectiveness, and affordability. With its reimbursement policies, SSI provides medicines to people under its system and takes measures to ensure that pharmaceutical expenditures do not exceed their budgets. As a result, in 2009 in Turkey, government requested cost-effectiveness and budget impact analysis from the innovative pharmaceutical products. This has required pharmaceutical companies to scientifically prove to the public that their products are cost-effective.

The first market access agreement has been signed for the products used in the treatment of Hepatitis C. The products have received reimbursement approval since June 18, 2016. The public discount rates have not been published for these products, and confidential discounting has been initiated. It was the first time the public discount rates kept confidential in Turkey.

The most involved pharmaceutical companies in the alternative reimbursement process were Roche, with five drugs, and Abbvie, Biomarin, Gilead, and Takeda with three drugs each. In countries where the prices of the drugs included in the List of Reimbursed Medicines for 4A and the alternative reimbursement process are taken as a reference, Switzerland is followed by Greece.

1. Report Description of the Turkey Dermatology Treatment Drugs Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Turkey Dermatology Treatment Drugs Market Analysis Executive Summary
2.1 Turkey Dermatology Treatment Drugs Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of Turkey Dermatology Treatment Drugs Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Rising expenditure on personal care
3.1.2 Rising number of patients suffering from acne
3.2 Market Restraints Analysis
3.2.1 Stringent Regulations for Dermatology Drugs
3.2.2 High Cost of Dermatology Drugs
3.3 Covid-19 Market Impact Analysis
4. Turkey Dermatology Treatment Drugs Market Segmentation
4.1 By Dermatological Diseases:
4.1.1 Acne
4.1.2 Dermatitis
4.1.3 Psoriasis
4.1.4 Skin Cancer
4.1.5 Others
4.2 By Drug Class:
4.2.1 Corticosteroids
4.2.2 Astringents
4.2.3 Anti-Inflammatory & Antipruritic Drugs
4.2.4 Anti-Infective/Antibacterial Drugs
4.2.5 Antifungal Drugs
4.3 By Prescription Mode:
4.3.1 Prescription based drugs
4.3.2 Over-the-counter drugs
4.4 By Route of Administration:
4.4.1 Topical
4.4.2 Oral
4.4.3 Parenteral Administration
4.5 By End-User:
4.5.1 Homecare
4.5.2 Hospitals
4.5.3 Dermatology Clinics
4.6 By Distribution Channel:
4.6.1 Retail Pharmacy
4.6.2 Hospitals Pharmacy
4.6.3 Online Pharmacy
4.6.4 Others
5. Turkey Dermatology Treatment Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives Dermatology Drug Market
6.4 Notable recent deals in Dermatology Drug Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Abbvie Inc. Company overview
Product & Services, Strategies & Financials
7.2 Johnson & Johnson Services, Inc. Company overview
Product & Services, Strategies & Financials
7.3 GlaxoSmithKline Plc. Company overview
Product & Services, Strategies & Financials
7.4 Eli Lilly and Company overview
Product &, Strategies & Financials
7.5 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.6 Glenmark Pharmaceuticals Ltd Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Dermatology Drug market
9.2 Future Opportunities
10. Strategic Recommendations

Turkey Dermatology Treatment Drugs Market Analysis Segmentation

By Drug Class:

On the basis of drug class, the market is segmented into corticosteroids, retinoids, monoclonal antibodies, antibiotics agent, antiviral agents, antifungal drugs, antihistamines agents, immunosuppressive drugs and others.

By Dermatological Disease:

By Dermatological Diseases it is segmented upon, Acne, Dermatitis, Psoriasis, Skin Cancer, Others.

By Prescription Mode:

On the basis of prescription mode, the market is segmented into prescription based drugs and over-the-counter drugs. Prescription based drugs segment dominate the Turkey dermatology drugs market, because maximum branded drugs sold via prescription based drugs mode over others in the United States.

By Route of Administration:

On the basis of route of administration, the market is segmented into oral, topical and parenteral.

By End-User:

On the basis of end user, the market is segmented into homecare, hospitals, dermatology clinics and others. Homecare segment dominate the Turkey dermatology drugs market due to high volume demand from this end use. Majority of acne and psoriasis drugs were sold in the market by this end use.

By Distribution Channel:

On the basis of distribution channel, the market is segmented into retail pharmacy, hospitals pharmacy, online pharmacy and others. Retail pharmacy segment dominate the Turkey dermatology drugs market due to well established retail distribution channel and cost effectiveness of this distribution channel.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements